Advertisement

HPV Testing of Head and Neck Cancer in Clinical Practice

  • Max RobinsonEmail author
Chapter
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 206)

Abstract

The pathology laboratory has a central role in providing human papillomavirus (HPV) tests for patients with head and neck cancer. There is an extensive literature around HPV testing and a large number of proprietary HPV tests, which makes the field difficult to navigate. This review provides a concise contemporary overview of the evidence around HPV testing in head and neck cancer and signposts key publications, guideline documents and the most commonly used methods in clinical practice.

Keywords

HPV Molecular diagnostics Head and neck p16 Immunohistochemistry In situ hybridisation 

References

  1. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bhatia A, Burtness B (2015) Human papillomavirus-associated oropharyngeal cancer: defining risk groups and clinical trials. J Clin Oncol 33(29):3243–3250CrossRefPubMedGoogle Scholar
  3. Chung CH, Zhang Q, Kong CS, Harris J, Fertig EJ, Harari PM et al (2014) p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. J Clin Oncol 32(35):3930–3938CrossRefPubMedPubMedCentralGoogle Scholar
  4. College of American Pathologists (2012) Protocol for the examination of specimens from patients with carcinomas of the pharynx. College of American Pathologists, USAGoogle Scholar
  5. Huang SH, Perez-Ordonez B, Liu FF, Waldron J, Ringash J, Irish J et al (2012) Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 82(1):276–283CrossRefPubMedGoogle Scholar
  6. ISO15189:2012. http://www.iso.org/iso/catalogue_detail?csnumber=56115 (Accessed 06.03.2016)
  7. Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M et al (2012) Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol 36(7):945–954CrossRefPubMedGoogle Scholar
  8. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1):9–22CrossRefPubMedGoogle Scholar
  9. Lewis JS Jr (2012) p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma. Head Neck Pathol 6(Suppl 1):S75–S82CrossRefPubMedGoogle Scholar
  10. Lewis JS Jr, Thorstad WL, Chernock RD, Haughey BH, Yip JH, Zhang Q et al (2010) p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol 34(8):1088–1096CrossRefPubMedGoogle Scholar
  11. Maxwell JH, Kumar B, Feng FY, McHugh JB, Cordell KG, Eisbruch A et al (2010) HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck 32(5):562–567PubMedPubMedCentralGoogle Scholar
  12. McCord C, Xu J, Xu W, Qiu X, McComb RJ, Perez-Ordonez B et al (2013) Association of high-risk human papillomavirus infection with oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol 115(4):541–549CrossRefPubMedGoogle Scholar
  13. Mehanna H, Franklin N, Compton N, Robinson M, Powell N, Biswas-Baldwin N et al (2016) Regional and geographic variability in human papillomavirus-associated oropharyngeal cancer: individual patient data and samples from four multi-national randomised trials. Head Neck. doi: 10.1002/hed.24336 PubMedCentralGoogle Scholar
  14. Mirghani H, Casiraghi O, Amen F, He M, Ma XJ, Saulnier P et al (2015) Diagnosis of HPV-driven head and neck cancer with a single test in routine clinical practice. Mod Pathol 28(12):1518–1527CrossRefPubMedGoogle Scholar
  15. National Cancer Comprehensive Network (2014) Clinical practice guidelines in oncology: head and neck cancers. National Cancer Comprehensive Network, USAGoogle Scholar
  16. Perrone F, Gloghini A, Cortelazzi B, Bossi P, Licitra L, Pilotti S (2011) Isolating p16-positive/HPV-negative oropharyngeal cancer: an effort worth making. Am J Surg Pathol 35(5):774–777CrossRefPubMedGoogle Scholar
  17. Rietbergen MM, Leemans CR, Bloemena E, Heideman DA, Braakhuis BJ, Hesselink AT, Witte BI, Baatenburg de Jong RJ, Meijer CJ, Snijders PJ, Brakenhoff RH (2013a) Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 132(7):1565–1571Google Scholar
  18. Rietbergen MM, Brakenhoff RH, Bloemena E, Witte BI, Snijders PJ, Heideman DA, et al (2013b) Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol 24(11):2740–2745Google Scholar
  19. Rietbergen MM, Witte BI, Velazquez ER, Snijders PJ, Bloemena E, Speel EJ, Brakenhoff RH, Kremer B, Lambin P, Leemans CR (2015) Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe. Br J Cancer 112(11):1733–1736CrossRefPubMedPubMedCentralGoogle Scholar
  20. Robinson M, Sloan P, Shaw R (2010) Refining the diagnosis of oropharyngeal cancer using human papillomavirus testing. Oral Oncol 46(7):492–496CrossRefPubMedGoogle Scholar
  21. Robinson M, Schache A, Sloan P, Thavaraj S (2012) HPV specific testing: a requirement for oropharyngeal squamous cell carcinoma patients. Head Neck Pathol. 6(Suppl 1):S83–S90CrossRefPubMedGoogle Scholar
  22. Robinson M, Suh YE, Paleri V, Devlin D, Ayaz B, Pertl L et al (2013) Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population. Infect Agent Cancer. 8(1):30CrossRefPubMedPubMedCentralGoogle Scholar
  23. Royal College of Pathologists (2013) Dataset for the reporting of mucosal malignancies of the pharynx. Royal College of Pathologists, UKGoogle Scholar
  24. Salazar CR, Anayannis N, Smith RV, Wang Y, Haigentz M Jr, Garg M et al (2014) Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer 135(10):2404–2412CrossRefPubMedPubMedCentralGoogle Scholar
  25. Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J et al (2011) Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 17(19):6262–6271CrossRefPubMedPubMedCentralGoogle Scholar
  26. Schache AG, Liloglou T, Risk JM, Jones TM, Ma XJ, Wang H et al (2013) Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma. Br J Cancer 108(6):1332–1339CrossRefPubMedPubMedCentralGoogle Scholar
  27. Schache A, Croud J, Robinson M, Thavaraj S (2014) Human papillomavirus testing in head and neck squamous cell carcinoma: best practice for diagnosis. Methods Mol Biol 1180:237–255CrossRefPubMedGoogle Scholar
  28. Singhi AD, Westra WH (2010) Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 116(9):2166–2173PubMedGoogle Scholar
  29. Smeets SJ, Hesselink AT, Speel EJ, Haesevoets A, Snijders PJ, Pawlita M et al (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121(11):2465–2472CrossRefPubMedGoogle Scholar
  30. Stenmark MH, McHugh JB, Schipper M, Walline HM, Komarck C, Feng FY et al (2014) Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys 88(3):580–588CrossRefPubMedPubMedCentralGoogle Scholar
  31. Thavaraj S, Stokes A, Guerra E, Bible J, Halligan E, Long A et al (2011) Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 64(4):308–312CrossRefPubMedGoogle Scholar
  32. Ukpo OC, Flanagan JJ, Ma XJ, Luo Y, Thorstad WL, Lewis JS Jr (2011) High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol 35(9):1343–1350CrossRefPubMedGoogle Scholar
  33. Weichert W, Schewe C, Denkert C, Morawietz L, Dietel M, Petersen I (2009) Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung. Am J Surg Pathol 33(4):513–520CrossRefPubMedGoogle Scholar
  34. Westra WH (2014) Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol 50(9):771–779CrossRefPubMedPubMedCentralGoogle Scholar
  35. Woo SB, Cashman EC, Lerman MA (2013) Human papillomavirus-associated oral intraepithelial neoplasia. Mod Pathol 26(10):1288–1297CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Oral PathologyCentre for Oral Health Research, Newcastle UniversityNewcastle upon TyneUK

Personalised recommendations